Cleveland Clinic and G42 have entered into a strategic collaboration to advance the adoption of artificial intelligence (AI) in healthcare, marking yet another major step in realizing AI’s potential in medicine. The partnership will create a joint task force to assess, prioritize, and expedite AI-powered efforts to enhance patient care, medical research, and operational efficiency.
G42, based in Abu Dhabi, UAE, is a global technology pioneer specializing in AI, digital infrastructure, and big data analytics. M42, the group’s healthcare subsidiary, operates 480 clinics in 26 countries and has led large health projects such as the Emirati Genome Program and Abu Dhabi’s health information exchange, Malaffi.
“Cleveland Clinic is committed to finding opportunities that improve patient safety, patient experience, patient outcomes, and access,” said Cleveland Clinic CEO and President Tom Mihaljevic, M.D. “Artificial intelligence offers a tremendous opportunity to continue to advance and fulfill our mission of caring for life, researching for health, and educating those who serve.”
